PERINATALHYPOXIC-ISCHEMICINJURY also see STROKES

 

Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats.                                                      (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16864698

 

Synergistic neuroprotective therapies with hypothermia.                   (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892736/?tool=pubmed

 

The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic- ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. (abst – 2010)          http://www.ncbi.nlm.nih.gov/pubmed/19900555

 

The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. (abst – 2010)                                           http://www.ncbi.nlm.nih.gov/pubmed/21115947

 

Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia- ischemia in newborn pigs.                                                              (abst – 2011)       http://www.ncbi.nlm.nih.gov/pubmed/21654550

 

The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia.                                                           (abst – 2011)        http://www.ncbi.nlm.nih.gov/pubmed/21909954

 

Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury. (abst – 2011)                                                         http://www.ncbi.nlm.nih.gov/pubmed/21788999

 

Therapeutic potential of the endocannabinoid system in perinatal asphyxia (abst – 2011)                                           http://www.ncbi.nlm.nih.gov/pubmed/22127663

 

Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats. (abst – 2012)                                         http://www.ncbi.nlm.nih.gov/pubmed/22841538

Share a link for